2016 annual financial data
Fate Therapeutics 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was -677.49%.
Operating income was -31,963,000 USD and net income was -33,462,000 USD.
Operating cash flow was -29,823,000 USD.
Get free Fate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,402,000 USD
- Operating income
- -31,963,000 USD
- Net income
- -33,462,000 USD
- Operating cash flow
- -29,823,000 USD